ENTITY

Rigel Pharmaceuticals (RIGL US)

2
Analysis
Health CareUnited States
Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. The Company's research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms.
more
Company Presentation05 Nov 2025 05:30
Company Presentation06 Aug 2025 04:30
Company Presentation06 Feb 2024 20:00
Company Presentation06 Aug 2024 19:00
Company Presentation06 May 2025 19:00
x